These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4543547)

  • 21. Preliminary report on some clinical and biochemical observations in patients treated with Bilharcid.
    Faríd F; Moussà AH; Abulfadl AM; El-Raziky EH; Adham I
    Egypt J Bilharz; 1975; 2(1):31-6. PubMed ID: 810341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatotoxicity after treatment of schistosomiasis with hycanthone.
    Farid Z; Smith JH; Bassily S; Sparks HA
    Br Med J; 1972 Apr; 2(5805):88-9. PubMed ID: 5018315
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro studies on the use of penicillamine with tartar emetic against Schistosoma mansoni worms.
    Henry W; Girgis NI; Mansour NS
    Ann Trop Med Parasitol; 1976 Dec; 70(4):425-9. PubMed ID: 999355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of schistosomal infection and of schistosomicidal drugs on the drug metabolizing enzymes of mouse liver.
    Ghazal A; Mahfouz M; Makar AB; Ghoneim MT
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(2):181-6. PubMed ID: 4368632
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening of three synthetic organic trivalent antimonials for potential antischistosomal activity in mice.
    Ghaleb HA; Shoeb H; el-Kawhary N; el-Borolossy AW; el-Halawany SA; Madkour MK
    J Egypt Med Assoc; 1979; 62(1-2):1-29. PubMed ID: 262466
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis of new praziquantel analogues: potential candidates for the treatment of schistosomiasis.
    Sadhu PS; Kumar SN; Chandrasekharam M; Pica-Mattoccia L; Cioli D; Rao VJ
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1103-6. PubMed ID: 22217873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A correlation between certain active trivalent antimony organic compounds and their structure as schistosomicidals.
    Abdulla WA; Nasr A; Abou-ouf AA
    Egypt J Bilharz; 1975; 2(1):63-81. PubMed ID: 1181173
    [No Abstract]   [Full Text] [Related]  

  • 28. Influence of the substituent radicals in antimonyl naphthalein derivatives on the potentialities of anti-schistosomal activity in mice.
    Ghaleb HA; Shoeb HA; el-Gawhary N; el-Borolossy AW; el-Halawany SA; MADKOUR MK
    J Egypt Med Assoc; 1979; 62(1-2):31-43. PubMed ID: 262474
    [No Abstract]   [Full Text] [Related]  

  • 29. The protective potentials of 4-chloro-3, 5-xylenol (Dettol) against Mansonian schistosomiasis.
    Edungbola LD
    Afr J Med Med Sci; 1980; 9(3-4):97-102. PubMed ID: 6283866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary observations on the in vitro lymphocyte transformation from mice infected with Schistosoma mansoni troughout treatment with an antimonial.
    Pérez H; Pérez M; Payares G
    Rev Bras Biol; 1973; 33(4):547-52. PubMed ID: 4548549
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of treatment with different antibilharzial drugs on renal functions in urinary schistosomiasis.
    el-Zayadi AM; Shoeb SM; Sabour MS; Basmy K
    Tropenmed Parasitol; 1974 Jun; 25(2):147-52. PubMed ID: 4418544
    [No Abstract]   [Full Text] [Related]  

  • 32. Experimental and clinical studies with a new antimonial preparation for the treatment of schistosomiasis.
    Pedrique MR; Ercoli N
    Bull World Health Organ; 1971; 45(4):411-7. PubMed ID: 5317079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of schistosomicides against experimentally established Schistosoma mansoni infections in mice and hamsters.
    Yarinsky A
    J Toxicol Environ Health; 1975 Nov; 1(2):229-42. PubMed ID: 1206769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of schistosomiasis mansoni: current aspects].
    Coutinho A
    AMB Rev Assoc Med Bras; 1977 Jan; 23(1):27-31. PubMed ID: 311025
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessment of 35972 RP (oltipraz) a new antischistosomal drug against Schistosoma haematobium, Schistosoma mansoni, and Schistosoma intercalatum.
    Gentilini M; Duflo B; Richard-Lenoble D; Brücker G; Danis M; Niel G; Meunier Y
    Acta Trop; 1980 Sep; 37(3):271-4. PubMed ID: 6106367
    [No Abstract]   [Full Text] [Related]  

  • 36. A method for detecting therapeutic activity against Schistosoma mansoni in mice.
    Campbell WC; Bartels E; Cuckler AC
    J Parasitol; 1978 Feb; 64(1):69-77. PubMed ID: 203672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current chemotherapy of schistosomiasis japonica in the Philippines.
    Santos AT
    Southeast Asian J Trop Med Public Health; 1976 Jun; 7(2):306-9. PubMed ID: 193200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of schistosomiasis mansoni].
    de Carvalho SA
    Rev Paul Med; 1982; 99(2):26-8. PubMed ID: 7156674
    [No Abstract]   [Full Text] [Related]  

  • 39. Antischistosomal activity of S-2-[[2-(2-thiazolylcarbamoyl) ethyl] amino] ethyl hydrogen thiosulfate in vitro and in vivo.
    Voigtman RE; Thompson PE
    J Parasitol; 1977 Dec; 63(6):1053-9. PubMed ID: 412938
    [No Abstract]   [Full Text] [Related]  

  • 40. Early liver dysfunction in schistosomiasis.
    Camacho-Lobato L; Borges DR
    J Hepatol; 1998 Aug; 29(2):233-40. PubMed ID: 9722204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.